A detailed history of Td Asset Management Inc transactions in Organon & Co. stock. As of the latest transaction made, Td Asset Management Inc holds 80,300 shares of OGN stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,300
Previous 35,200 128.13%
Holding current value
$1.17 Million
Previous $728,000 110.99%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$18.65 - $23.03 $841,114 - $1.04 Million
45,100 Added 128.13%
80,300 $1.54 Million
Q2 2024

Aug 02, 2024

BUY
$17.45 - $21.96 $614,240 - $772,992
35,200 New
35,200 $728,000
Q3 2023

Oct 27, 2023

SELL
$16.59 - $23.77 $14,931 - $21,393
-900 Reduced 1.59%
55,545 $964,000
Q2 2023

Aug 09, 2023

BUY
$19.27 - $24.63 $501 - $640
26 Added 0.05%
56,445 $1.17 Million
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $193,958 - $290,484
9,055 Added 19.12%
56,419 $1.33 Million
Q4 2022

Feb 06, 2023

SELL
$23.31 - $28.61 $24,079 - $29,554
-1,033 Reduced 2.13%
47,364 $1.32 Million
Q3 2022

Nov 07, 2022

BUY
$23.4 - $34.25 $12,729 - $18,632
544 Added 1.14%
48,397 $1.14 Million
Q2 2022

Aug 04, 2022

SELL
$31.66 - $38.9 $216,744 - $266,309
-6,846 Reduced 12.52%
47,853 $1.62 Million
Q1 2022

May 10, 2022

BUY
$30.45 - $39.36 $230,628 - $298,112
7,574 Added 16.07%
54,699 $1.91 Million
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $601,095 - $778,467
-20,966 Reduced 30.79%
47,125 $1.44 Million
Q3 2021

Nov 09, 2021

BUY
$28.63 - $35.64 $6,470 - $8,054
226 Added 0.33%
68,091 $2.23 Million
Q2 2021

Aug 11, 2021

BUY
$28.45 - $38.0 $1.93 Million - $2.58 Million
67,865 New
67,865 $1.97 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.